As of May 13, 1996, you will need to
register to access many parts of HDCN, including most of the article and
abstract summaries, discussion threads, etc.
Selected Abstracts
Dialysis, Chronic Renal Failure
Home hemodialysis
d 
Better control of anemia by daily hemodialysis
d
Optimal blood pressure control with daily hemodialysis
d
Experience with prolonged nocturnal hemodialysis
d
Are internal jugular vein catheters suitable for daily home
hemodialysis?
Cardiovascular/Hypertension
d
Two Vietnamese patients with refractory hypertension: lessons learned
GI/Liver, Hepatitis
d
Seroconversion rates with hepatitis B vaccination in PD patients
Skin
d
Odansetron; a novel therapeutic approach in the treatment of uremic
pruritus
Anemia/Erythropoietin/Iron
d
Reduction of rHuEPO doses by bolus intravenous iron therapy in CAPD
patients
d
Protocol for intraperitoneal erythropoietin
CRF in infants and children
d
Peritoneal vs hemodialysis for children at centers specializing in
pediatric vs adult care
Outcomes (Morbidity, Mortality)
d
Neither size nor weight predicts survival in PD patients
PD solutions, equipment
d
Nutritional effect of 1.1% amino-acid containing dialysate in
Japanese malnourished CAPD patients: a multicenter study
PET testing
d
Serum albumin and peritoneal equilibration test
d
Peritoneal transport rates do not correlate with nutritional
status in Mexican CAPD patients
d
Standardization of pediatric PET test: Results with a dwell
volume of 1200 mL/m2
d
Protein losses during CAPD
d
Immunohistochemical detection of advanced glycation end-products
(AGEs) in the peritoneum and its possible pathophysiological role in CAPD
d
APEX Time (Accelerated Peritoneal Examination) is a more sensible tool
than simplified PET for follow-up of long term peritoneal alterations
PD procedure: tips
d
A cost comparison of dialysis vendor provided vs. PD program provided
general medical supplies
Peritonitis and exit-site infection
d
Treatment of exit-site infection: a randomized trial on ampicillin
plus cloxacillin, ofloxacin, and local mupirocin
d
Pseudomonas peritonitis management
d
Usefulness of endotoxin test for assessing CAPD peritonitis by
gram-negative organisms
d
Vancomycin-resistant enterococcal peritonitis
d
Factors predicting the development of fungal peritonitis in chronic PD
patients
d
Oral fluconazole therapy for the prevention of fungal
peritonitis in PD patients
d
Treatment of CAPD-related peritonitis with ciprofloxacin: results
after 8 years
d
A new technique of cuff shaving in CAPD patients
d
Gram-negative peritonitis: improved outcome with IP ceftazidime
d
Acute treatment of constipation may lead to transmural migration of
bacteria resulting in gram negative, polymicrobial, or fungal
peritonitis
Chronic PD regimens, adequacy, modeling
d
How much additional expense is incurred whan an "adequacy
program" is implmented in the peritoneal dialysis unit
d
CAPD patient and technique survivals are worse with increased
membrane permeability
d
Clinical evaluation of a peritoneal dialysis kinetic modeling set
d
Continuous peritoneal dialysis is large weight individuals
Lipids
d
(1) Gemfibrozil, (2) pravastatin, and (3) omega-3 fatty
acid treatment of dyslipidemia in CAPD patients 3 abstracts
Use back arrow on your browser to go back to HDCN home page (faster)
or click on the arrow.